Nacha Cattan
-
NYC’s Priciest Apartments Hit Lowest Vacancy Rate In 30 Years
The vacancy rate for New York City’s most-expensive rentals plunged to 3.4% last year, the lowest in almost three decades.
-
NYC’s Priciest Apartments Hit Lowest Vacancy Rate In 30 Years
The vacancy rate for New York City’s most-expensive rentals plunged to 3.4% last year, the lowest in almost three decades.
-
Merck Looks To Join The Obesity Drug Frenzy
Merck & Co. is seeking new obesity-fighting drugs called GLP-1s, joining a host of companies angling for a slice of the exploding market.
-
Big Pharma Wants To Use AI To Increase Diversity In Clinical Trials
A medicine's effectiveness can vary across racial and ethnic groups, and drugmakers such as Johnson & Johnson are hoping to expand participation beyond the overwhelmingly White populations in current testing.
-
Pfizer’s $9 Billion Covid Outlook Cut Shows Depth Of Decline
Plummeting demand for Covid shots and pills caused Pfizer Inc. to cut $9 billion from its total annual sales guidance as the drug giant grapples with a stark decline for what had been marquee products.
-
Pfizer Cuts Guidance On Weakening Demand For Covid Antiviral Paxlovid
The drugmaker has been struggling to manage the rapid decline of its Covid business, and U.S. government inventory was preventing the company from making more off its pills that treat the virus by selling it through the private U.S. health-care system.
-
Pfizer Cuts Guidance On Weakening Demand For Covid Antiviral Paxlovid
The drugmaker has been struggling to manage the rapid decline of its Covid business, and U.S. government inventory was preventing the company from making more off its pills that treat the virus by selling it through the private U.S. health-care system.
-
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company seeks new revenue paths after one top-selling drug lost patent exclusivity and others face competition later this decade.
-
Eli Lilly Drug Slows Alzheimer’s Disease, Study Finds
The drug, donanemab, slowed the disease by 35% over a year and a half in a trial of 1,182 patients with early-stage Alzheimer’s, Lilly said.
-
Mexico Tells Oil Giant Pemex ‘You’re on Your Own’ to Cover Debt Payments
Mexico Tells Oil Giant Pemex ‘You’re on Your Own’ to Cover Debt Payments
-
AMLO’s Daily, Unending Speeches Are Fertile Ground for Surprises
AMLO’s Daily, Unending Speeches Are Fertile Ground for Surprises
-
Mexico Looks to Suspend Crude Export Cuts as Prices Rally
Mexico Looks to Halt Plan to Cut Crude Exports as Prices Rally
-
Mexican Local Bonds Are a Bargain as Selloff Risk Seen Contained
Mexican Local Bonds Are a Bargain as Selloff Risk Seen Contained
-
Mexico Finance Chief Readies Infrastructure Plan to Jump-Start Economy
Mexico Finance Chief Readies Infrastructure Plan to Jump-Start Economy
-
America Movil’s Slim Takes On AT&T in Fight Over TV License
America Movil’s Slim Takes On AT&T in Fight Over TV License
